camptothecin has been researched along with edotecarin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Animati, F; Berettoni, M; Bigioni, M; Binaschi, M; Cipollone, A; Irrissuto, C; Nardelli, F; Olivieri, L | 1 |
| Teicher, BA | 1 |
| David, K; Drappatz, J; Gerard, M; Kesari, S; McNamara, MB; Muzikansky, A; Norden, AD; Phan, P; Ross, A; Wen, PY | 1 |
| Arakawa, Y; Okawa, Y; Ozaki, K; Yamada, H | 1 |
1 review(s) available for camptothecin and edotecarin
| Article | Year |
|---|---|
Next generation topoisomerase I inhibitors: Rationale and biomarker strategies.
Topics: Animals; Antineoplastic Agents; Biomarkers; Camptothecin; Carbazoles; Humans; Indenes; Indoles; Isoquinolines; Naphthyridines; Topoisomerase I Inhibitors | 2008 |
3 other study(ies) available for camptothecin and edotecarin
| Article | Year |
|---|---|
Synthesis and biological evaluation of rebeccamycin analogues modified at the imide moiety.
Topics: Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Humans; Imides; Mice; Ovarian Neoplasms; Structure-Activity Relationship; Transplantation, Heterologous | 2012 |
An exploratory survival analysis of anti-angiogenic therapy for recurrent malignant glioma.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Camptothecin; Carbazoles; Clinical Trials as Topic; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Quinazolines; Survival Analysis | 2009 |
Three missense mutations of DNA topoisomerase I in highly camptothecin-resistant colon cancer cell sublines.
Topics: Apoptosis; ATP-Binding Cassette Transporters; Blotting, Western; Camptothecin; Carbazoles; Cell Cycle; Cell Proliferation; Colonic Neoplasms; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Mutation, Missense; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 2013 |